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Abstract
Background: Polycomb-group (PcG) and trithorax-group (trxG) proteins regulate histone methylation to establish repressive
and active chromatin configurations at target loci, respectively. These chromatin configurations are passed on from mother
to daughter cells, thereby causing heritable changes in gene expression. The activities of PcG and trxG proteins are
regulated by a special class of proteins known as Enhancers of trithorax and Polycomb (ETP). The Drosophila gene Additional
sex combs (Asx) encodes an ETP protein and mutations in Asx enhance both PcG and trxG mutant phenotypes. The mouse
and human genomes each contain three Asx homologues, Asx-like 1, 2, and 3. In order to understand the functions of
mammalian Asx-like (Asxl) proteins, we generated an Asxl2 mutant mouse from a gene-trap ES cell line.
Methodology/Principal Findings: We show that the Asxl2 gene trap is expressed at high levels in specific tissues including
the heart, the axial skeleton, the neocortex, the retina, spermatogonia and developing oocytes. The gene trap mutation is
partially embryonic lethal and approximately half of homozygous animals die before birth. Homozygotes that survive
embryogenesis are significantly smaller than controls and have a shortened life span. Asxl2
2/2 mice display both posterior
transformations and anterior transformation in the axial skeleton, suggesting that the loss of Asxl2 disrupts the activities of
both PcG and trxG proteins. The PcG-associated histone modification, trimethylation of histone H3 lysine 27, is reduced in
Asxl2
2/2 heart. Necropsy and histological analysis show that mutant mice have enlarged hearts and may have impaired
heart function.
Conclusions/Significance: Our results suggest that murine Asxl2 has conserved ETP function and plays dual roles in the
promotion of PcG and trxG activity. We have also revealed an unexpected role for Asxl2 in the heart, suggesting that the
PcG/trxG system may be involved in the regulation of cardiac function.
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Introduction
Polycomb Group (PcG) proteins and their antagonists, trithorax
Group (trxG) proteins, were identified in Drosophila as transcrip-
tional repressors and activators of homeotic genes (Hox genes),
respectively [1–3]. Mutations in PcG and trxG genes disrupt the
specification of anterior-posterior (A/P) positional information and
lead to homeotic transformations. In addition to their roles in A/P
patterning, PcG and trxG proteins are involved in many
developmental processes and diseases [4–7]. They have been
found to regulate the expression of hundreds of genes in mammals,
insects, and plants.
PcG and trxG proteins function at the level of chromatin, and
their functional mechanisms are highly conserved. PcG proteins
function by forming three multi-protein complexes, PRC1, PRC2,
and PhoRC. Genetic and biochemical studies have led to the
current model in which the complexes work together to establish
and maintain methylation marks, primarily on the tail of histone
H3 [4–8]. The PhoRC complex contains sequence-specific DNA
binding activity and also interacts with mono- and di-methylated
lysine 27 of histone H3 (H3K27) [9–11]. It has been proposed that
PhoRC plays the critical role of recognizing hypomethylated
nucleosomes around upstream regulatory elements of PcG target
genes. The PRC2 complex contains histone methyl-transferase
(HMTase) activity that trimethylates H3K27 [12–14]. H3K27me3
is a well-known mark for silenced chromatin and is associated with
promoters and regulatory elements of PcG target genes. The
PRC1 complex binds H3K27me3 and prevents chromatin
remodeling, thereby maintaining target chromatin regions in the
silenced state [15,16].
trxG proteins also function in multi-subunit complexes. Three
trxG complexes, the SET1-like complex, the BRM complex and
the MLL supercomplex, have been purified in mammalian cells.
The SET1-like complex contains HMTase activities and trimethy-
lates lysine 4 of histone H3 [17]. H3K4me3 is tightly associated
with the promoter regions of transcriptionally active loci [18–19].
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ATPase BRM and mediates ATP-dependent nucleosome sliding
[20]. The MLL supercomplex contains both HMTase activities
and chromatin remodeling activities [21].
PcG and trxG mutations have opposite effects on axial
patterning. PcG mutations cause posterior transformations and
trxG mutations cause anterior transformations [22]. In addition,
genetic experiments in Drosophila show that most PcG and trxG
mutations are reciprocally suppressive. These observations are
consistent with the opposing functions of PcG and trxG proteins to
establish silenced and active chromatin structures, respectively.
Surprisingly, mutations in a set of genes originally identified as
PcG genes [Asx, E(z), E(Pc), Psc, Scm and Su(z)2] were later found to
enhance trxG phenotypes [23]. Further studies suggest that these
genes play dual roles in PcG-mediated transcriptional repression
and trxG-mediated transcriptional activation of Hox genes. The
genes were proposed to form the ‘‘Enhancers of trithorax and
Polycomb’’ (ETP) group, which is distinct from both PcG and
trxG [23]. More ETP genes have since been identified and added
to the list [24–25]. Despite the importance of ETP genes in
promoting PcG and trxG activity, the mechanism by which ETP
proteins function is largely unknown. One hypothesis suggests that
ETP proteins may help recruit PcG and trxG complexes to target
chromatin. Consistent with this hypothesis, a few ETP proteins
have been shown to associate with PcG complexes at least
transiently [26–27]. Moreover, several ETP proteins have been
localized to the nucleus and on polytene chromosomes, including
two that bind to upstream maintenance elements of Hox genes
[28–30].
The Drosophila Additional sex combs (Asx) gene was one of the 6
original ETP genes identified [23]. Mutations in Asx cause both
posterior transformation (PcG phenotype) and anterior transfor-
mation (trxG phenotype) [31]. In addition, Asx genetically interact
with both PcG and trxG genes [32–33]. Consistent with the
hypothesized role of ETP proteins in PcG and trxG recruitment to
target chromatin, Asx is a nuclear protein that binds distinct loci
on polytene chromosomes [30]. However, it is not known with
which PcG/trxG protein(s) Asx interacts, what biochemical
activity it has, or which development process(es) it regulates. Most
published studies on Drosophila Asx were performed with gain-of-
function or hypomorph alleles, complicating the interpretation of
data.
The mouse and human genomes each contain three Asx
homologues, Asx-like 1, 2, and 3 [34–36]. In order to understand
the role of ETP in mammals, we have generated gene trap mutant
mice for Asx-like 2 (Asxl2). Analyses of Asxl2 mutant mice suggest
that murine Asxl2 has conserved functions in the regulation of PcG
and trxG. Furthermore, we found an unexpected role for Asxl2 in
the regulation of heart function.
Results
Generation of Asxl2 mutant mice
To generate mice mutant for Asxl2, we took advantage of the
gene-trap ES cell line AQ0356 made by the Gene-Trap Consortium
[37].In theAQ0356 line,the gene trap cassette integratedwithinthe
first intron of Asxl2. We mapped the exact site of integration to
5016 bp downstream of exon 1 (Fig. 1A). Comparison of the
sequence of the 15-kb mAsxl2 intron 1 to homologous sequences in
human and rat showed that the gene trap insertion does not disrupt
any conserved sequence module (Fig. 1B). Using RT-PCR, we
confirmed that transcription of the trapped allele (Asxl2
2) produces
an mRNA in which the first exon of Asxl2 is joined to the gene trap
cassette (Fig. 1C). The cassette contains a polyA signal at the 39 end,
interrupting endogenous splicing and causing translation to stop.
Thus, the Asxl2
2 allele encodes a fusion protein containing the first
19 amino acids of Asxl2 joined to the b-geo reporter (Fig. 1D). This
fusion protein is likely functionally null because it is missing all the
conserved domains of wild-type Asxl2. We injected AQ0356 cells
into mouse blastocysts to generate gene-trapped mice. The wild-type
and the Asxl2
2 alleles are readily distinguishable by genotyping PCR
(Fig. 1E).
To determine whether the insertion of the gene trap cassette
prevents the production of wild-type Asxl2 transcript, we have used
real-time PCR to measure the level of Asxl2 transcripts in the
heart, where Asxl2 is normally expressed abundantly. The level of
Asxl2 transcripts in the mutant heart is ,3% of the wild-type level
(Fig. 1F), suggesting that the gene trap insertion effectively though
not completely prevented production of wild-type transcripts. The
residual level of Asxl2 transcripts could be the result of residual
endogenous splicing, or it could represent a low level of
transcription isoform produced from an alternative promoter
downstream of the gene trap integration site. We conclude that
Asxl2
2 is a severe loss-of-function allele.
The expression pattern of the Asxl2 gene trap in
developing embryos and postnatal tissues
Because gene trapping puts the beta-gal reporter under the
transcriptional control of the endogenous gene’s promoter, lacZ
expression often reflects the expression pattern of the endogenous
gene. X-gal stainings showed that the Asxl2 gene trap is expressed
at low levels broadly and at high levels in a tissue-specific manner
in developing embryos (Fig. 2A–D). In particular, the Asxl2 gene
trap is highly expressed in the heart at all developmental stages
examined, starting in E9.5 embryos (Fig. 2A) and continuing
throughout embryogenesis (Fig. 2B–D). Strong expression was also
detected in the axial skeleton, where PcG/trxG proteins have a
well-known role in the regulation of anterior-posterior patterning.
Other embryonic organs that express the Asxl2 gene trap at high
levels include the neocortex, the spinal cord and the eye.
The postnatal expression of the Asxl2 gene trap is highly tissue-
specific. Expression was detected in the heart, the retina, the ovary
and the testis (Fig. 2E, F, H–J), but not in the liver, the brain, the
spleen, the pancreas, or the lung (data not shown). While the Asxl2
gene trap is ubiquitously expressed in the cardiac muscle, it is not
expressed in the skeletal muscle (compare Fig. 2F and 2G). In the
retina, the Asxl2 gene trap is expressed in the outer nuclear layer
and in a subset of cells in the ganglion cell layer (Fig. 2H). The
Asxl2 gene trap is also expressed during gametogenesis of both
sexes. Its expression during spermatogenesis is restricted to the
primary spermatocytes and is not detectable in secondary
spermatocytes and other post-meiotic (haploid) cells (Fig. 2I). In
the ovary, the Asxl2 gene trap is expressed in the oocyte in follicles
of all stages (Fig. 2J and data not shown).
Asxl2 is required for embryonic and postnatal
development
When Asxl2
+/2 animals were backcrossed to wild-type mice, the
genotypes of pups segregated at the expected 1:1 ratio. However,
among 220 pups born to matings between heterozygous parents,
only 28 were homozygous mutants (Asxl2
2/2), significantly less
than the Mendelian ratio (Table 1). Among the 28, 23 survived to
weaning and 5 died within 2–3 days of birth. The number of
homozygous pups was less than half of what was expected,
suggesting that more than half of Asxl2
2/2 mice died before birth.
The exact time and cause of embryonic loss has not been
determined.
Mouse Asxl2 Regulates PcG/TrxG
PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4750Figure 1. Generation of Asxl2 mutant mice. (A) Schematic representation of the gene trap allele of murine Asxl2 (not drawn to scale). Exon 1
contains the 5’UTR (the narrow portion of the red box) and coding sequence for the first 19 amino acids of Asxl2. The gene trap cassette (blue
rectangle) is inserted 5,016 bp downstream of exon 1. P1, P2 and P3: primers used in genotyping PCRs. R1, R2 and R3: primers used in RT-PCR analysis
of the wild-type and gene trapped transcripts. (B) Conservation between mouse Asxl2 intron 1 and corresponding sequences in human ASXL2 and rat
Asxl2 loci. The mouse, human and rat sequences were compared by SLAGAN. The 15,261-bp intron 1 of mouse Asxl2 was used as the base sequence.
The top two panels show distribution of conserved sequence modules within the entire length of mouse Asxl2 intron 1. The bottom two panels show
close-up views of 500 bp upstream and 500 bp downstream of the gene trap insertion site, which is indicated by red arrows. (C) RT-PCR analysis of
the AQ0356 gene trap ES cell line. Transcripts from the wild-type (+) and mutant (2) alleles are detected with primer sets R1/R2 and R1/R3,
respectively. The RT-PCR product in the mutant lane reflects splicing event that joins exon 1 with b-geo. (D) Schematic representation of the domain
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2/2 mice that survived past weaning fall into two
categories. A small number (5 out of 23, or 21.7%) of the
surviving mutants were runts. The runt mutants weighed an
average of ,4.7 grams at 3 weeks, less than 40% of the normal
weaning weight (Fig. 3A). Although we kept the runt mutants with
their mothers beyond the normal weaning age, the animals failed
to thrive and remained extremely small. All runts died prema-
turely within two months of birth. The rest (18 out of 23, or
78.3%) of the mutants were also smaller than control littermates
(Fig 3A), but they were successfully weaned and steadily gained
weight as they grew older (Fig. 3B). We refer to these animals as
non-runt mutants. The average weaning weights for non-runt
mutant males and females were 7.5 grams and 9.5 grams,
respectively (Fig 3A). Despite their small size, we did not find gross
morphological abnormality in either runt or non-runt mutant
structures of Drosophila Asx, vertebrate Asxl1, Asxl2, Asxl3 and the predicted protein product from the Asxl2
2 allele. The ASXH (green box) and PHD
(red box) domains are conserved from flies to mammals. The ASXL1 boxes 1 and 2 (blue and orange boxes) are conserved in the three mammalian
Asx-like proteins but are not present in Asx. The mutant protein contains the first 19 amino acids of Asxl2 joined to b-geo. None of the conserved
domains is present in the mutant protein. (E) PCR genotyping of genomic DNA from Asxl2 wild-type (+/+), heterozygous (+/2) and mutant (2/2)
mice. P1 and P2 generate a 250-bp product from the wild-type allele. P1 and P3 generate a 480-bp product from the mutant allele. (F) Real-time RT-
PCR quantification of wild-type Asxl2 transcripts in Asxl2 wild-type (+/+), heterozygous (+/2) and mutant (2/2) hearts. The transcript levels in
heterozygous and mutant hearts were 52.1% and 3.0% of that in wild-type hearts, respectively.
doi:10.1371/journal.pone.0004750.g001
Figure 2. The expression pattern of the Asxl2 gene trap in developing embryos and adult organs. Developing embryos and postnatal
organs were stained with X-gal. (A) A whole-mount E9.5 embryo. (B–D) Cryo-sections of whole-mount stained E10.5 (B), E12.5 (C) and E14.5 (D)
embryos. (E) Top view of a whole-mount stained postnatal heart showing strong X-gal staining in the heart but not in the aorta. (F) Cryo-section of a
whole-mount stained postnatal heart. (G) Cryo-section of a piece of whole-mount stained skeletal muscle. The skeletal muscle in (G) and the heart in
(F) were taken from the same animal and stained together. There was no detectable X-gal activity in the skeletal muscle. (H) Cryo-section of the retina
in a whole-mount stained eye. Arrows point to stained cells in the ganglion cell layer. (I) Cross-section of a seminiferous tubule in a whole-mount
stained testis showing expression in the primary spermatocytes. (J) Cross-section of an early tertiary follicle in a whole-mount stained ovary, showing
expression in the oocyte (arrow). The blue color around the periphery of the follicle (arrowhead) was non-specific and also detected in wild-type
samples. Phr: 1st pharyngeal arch; A: common atrial chamber; AS: aorta sac; SV: sinus venosus; Som: somites; V: common ventricular chamber; TA:
truncus arteriosus; H: heart; AS: axial skeleton; NC: neocortex; RV: right ventricle; LV: left ventricle; ONL: outer nuclear layer.
doi:10.1371/journal.pone.0004750.g002
Table 1. Recovered progeny of intercrosses between Asxl2
+/2
mice.
Total number of pups Genotype
+/++ /22 /2
Actual number 220 58 137 28
Expected* number n/a 58 116 58
Chi square n/a n/a 0.935 10.465
p value n/a n/a 0.33 0.0012
*based on the number of wild-type pups.
doi:10.1371/journal.pone.0004750.t001
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died soon after birth, all the subsequent analyses were done with
non-runt mutants.
Asxl2 mutant skeletons display both posterior and
anterior transformations
PcG and trxG proteins play central roles in the repression and
activation of Hox genes, respectively. In mouse PcG and trxG
mutants, the expression of Hox genes is misregulated, leading to
abnormal patterning of the axial skeleton. Consistent with the
expression of the Asxl2 gene trap in the axial skeleton (Fig. 2) and
with the hypothesis that the mouse Asxl2 is part of the PcG/trxG/
ETP system, analyses of whole-mount skeletons of Asxl2
2/2 mice
revealed a number of axial skeletal abnormalities that are
reminiscent of skeletal phenotypes observed in PcG, trxG, ETP
and Hox mutant mice (Fig. 4, summarized in Table 2). The most
penetrant phenotype involves the sacrum of all mutant mice. Mice
normally have four sacral vertebrae (S1–4) with wing-shaped
lateral processes. In all (7 out of 7) wild-type skeletons examined,
S1–3 fuse at the tip of their lateral processes to form the articular
surface that contacts the ilium, while S4 does not fuse with S3
(Fig. 4A). In contrast, the lateral processes of S1–3 fail to fuse in all
(13 out of 13) Asxl2
2/2 skeletons examined (Fig. 4B). Absence of
fusion between S1/S2 or S2/S3 suggests that S2 and S3 may have
Figure 3. Growth defect in Asxl2
2/2 animals. (A) Comparison of body weights at weaning (3 weeks) for wild-type (blue columns), heterozygous
(green columns), runt mutant (red columns) and non-runt mutant (black columns) mice. Error bars stand for standard deviation. M: males. F: females.
(B) Growth of wild-type (blue line), heterozygous (green line) and non-runt mutant (black line) animals. Body weights were measured every two
weeks after weaning and plotted against time. Animals of all three genotypes gained weight over time, but the weight gap between non-runt
mutants and wild-type or heterozygous animals widens from 3 to 5 weeks and remains wide throughout the time course of measurements. The
growth curve of runt mutants was not generated because very few runt mutants were born and all died early.
doi:10.1371/journal.pone.0004750.g003
Figure 4. The loss of Asxl2 disrupts axial skeleton patterning. (A, B) Ventral view of the sixth lumbar vertebra (L6) and the sacral vertebrae 1–4
(S1–4). (A) A wild-type skeleton. The wing-shaped lateral processes of S1, S2 and S3 fuse at the tip (arrowheads). The lateral processes of S4 do not
fuse with those of S3. (B) A mutant skeleton. The lateral processes of S1, S2 and S3 fail to fuse. Arrowheads point to the sites at which fusion should
happen. The lateral processes of mutant S2 resemble those of wild-type S3; those of mutant S3 resemble those of wild-type S4. One of the lateral
processes of mutant L6 resembles that of S1 (arrow). (C, D) Caudal view of isolated T6 and T7 vertebrae, showing anterior transformation in the
mutant. The wild-type T6 and T7 differ in the length of the neural spine (arrows) and the arch of the attached ribs (C). The mutant T7 resembles T6 in
both the neural spine and the arch of ribs. (E, F) Caudal view of the first thoracic vertebrae (T1) in a heterozygous skeleton (E) and a mutant skeleton
(F). The mutant T1 is split at the dorsal midline (asterisk).
doi:10.1371/journal.pone.0004750.g004
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observation that the lateral processes of mutant S3 resemble those
of wild-type S4 (Fig. 4B) (100% penetrance). 46% (6 out of 13) of
mutant skeletons also exhibit transformation of S2 to S3 (Fig. 4B,
Table 2). A partial transformation of L6 to S1 was observed in a
small number (2 out of 13) of mutant skeletons (Fig. 4B) but not in
any wild-type or heterozygous skeleton. Because posterior
transformation is a classical PcG mutant phenotype, these
observations suggest that the loss of Asxl2 disrupts PcG activity.
Anterior transformation was also observed in Asxl2
2/2
skeletons. In all wild-type skeletons examined, the 7
th thoracic
vertebra (T7) and the 6
th thoracic vertebra (T6) can be
distinguished by the length and shape of the neural spine and by
the arch of the attached ribs (Fig. 4C). In 23% (3 out of 13) of
mutant skeletons, there appeared to be two T6 vertebrae and no
T7 vertebra because the mutant T7 resembles that of T6 in both
neural spine and rib arch (Fig. 4D). Anterior transformation of T4
to T3 was also observed in 15% (2 out of 13) of mutant skeletons,
but not in wild-type or heterozygous skeletons (Table 2). Because
anterior transformation is a classical phenotype for trxG
mutations, these observations suggest that the loss of Asxl2 also
disrupts trxG activity.
Another prominent feature of Asxl2
2/2skeleton is splitting of
the vertebrae at the dorsal midline, which was observed at multiple
locations along the cervical and thoracic vertebral columns of
Asxl2
2/2animals (Fig. 4E, F and Table 1). Whether and how the
split vertebrae are related to anterior or posterior transformation is
unclear. However, split vertebrae have been previously observed
in mice mutant for the ETP gene Bmi-1, for the PcG gene Ring1a,
and for the gene Taspase1 encoding an enzymatic processor of the
trxG protein MLL [38–40]. Thus, the split vertebrae phenotype in
Asxl2
2/2skeleton is consistent with the hypothesis that murine
Asxl2 functions in the same processes as PcG, trxG and ETP
proteins do.
Asxl2 mutant animals die prematurely with enlarged
hearts
Although the non-runt mutants lived past weaning and grew in
size, they remained significantly smaller than control littermates.
Furthermore, they became lethargic and moribund as they aged,
dying prematurely between 2 and 7 months. Necropsy of three
moribund non-runt mutant mice showed that they have
disproportionally large hearts when compared to their small body
size. Histological examination found signs of myocyte disarray and
interstitial fibrosis in the hearts of older, moribund mutant animals
(Fig. 5B, D), but not in age-matched control animals (Fig. 5A, C)
or in younger mutants (data not shown). This suggests that the old
mutants had decreased heart function and may have experienced
heart failure. We compared the heart/body weight ratio of mutant
animals at various ages with that of age- and sex-matched
littermates. The average heart/body weight ratios were higher in
mutant animals than in control animals at all three time points
(Fig. 5E). The difference between mutants and controls were
statistically significant in 2-month-old and 3-month-old animals
(p=0.03 and p=0.02, respectively). This suggests that an enlarged
heart could be a primary condition that existed before the animals
became visibly sick. The increased heart/body weight ratio is
unlikely an artifact of the mutant animals’ growth defect, because
the liver/body weight ratio is comparable between the mutant and
control animals (data not shown). An enlarged heart in humans is
a symptom associated with a number of cardiovascular diseases
and is often found during heart failure. Although the exact cause
of death is not known for Asxl2
2/2 animals, heart enlargement in
these animals may have compromised heart function and
contributed to the animals’ deteriorating health.
Asxl2
2/2 hearts have reduced level of H3K27me3
Histone methylation plays a central role in the mechanisms by
which PcG and trxG proteins mark the chromatin of their target
genes for repression or activation, respectively. The functions of
PcG complexes converge on the trimethylation of lysine 27 of
histone H3 [12–15], therefore the level of H3K27me3 provides a
readout of overall PcG activity. The mechanisms by which trxG
complexes modulate chromatin structure include both non-
covalent, ATP-dependent nucleosome sliding and covalent
modification of histone tails. Two of the three known mammalian
trxG complexes contain HMTase activity that trimethylates lysine
4 of histone H3 (H3K4me3). Because the axial skeletal phenotypes
of Asxl2
2/2 animals suggest that the loss of Asxl2 disrupts PcG and
trxG activities, we examined the global levels of H3K27me3 and
H3K4me3 in the hearts of Asxl2
+/+ and Asxl2
2/2 animals. We
found that mutant hearts had a lower level of H3K27me3 than
wild-type hearts (Fig. 5F), suggesting that PcG-associated methyl-
transferase activity is compromised in Asxl2
2/2 heart. The
reduction in H3K27me3 levels in mutant hearts were observed
in all four mutant-control littermate pairs that we examined. On
the other hand, the level of H3K4me3 did not exhibit obvious
difference between the same sets of mutant and wild-type hearts
(Fig. 5G), suggesting that the HMTase activity of trxG complexes
is not disrupted by the loss of Asxl2, or the disruption is subtle and
hence difficult to detect by semi-quantitative Western blotting.
Discussion
Expression pattern of Asxl2
The Asxl2 gene trap is expressed in a tissue-specific manner in
both embryos and adult animals (Fig. 2). Drosophila Asx has been
previously shown to be ubiquitously expressed from the blasto-
derm stage and on in the embryos [30]. There was no distinct
Table 2. Summary of skeletal defects observed in Asxl2
deficient mice.
Genotype +/++ /22 /2
#skeletons examined 7 10 13
Split C1 0 0 3 (23.1%)
Split C2 0 0 2 (15.4%)
Split C5 0 0 1 (7.7%)
Split C6 0 0 1 (7.7%)
Split T1 0 0 7 (53.8%)
T4 to T3 0 0 2 (15.4%)
T7 to T6 0 0 3 (23.1%)
Split T11 0 0 1 (7.7%)
T13 rib on one side 0 1 (10.0%) 0
L6 to S1 on one side 0 0 2 (15.4%)
S1/2 do not fuse 0 0 13 (100%)
S2 to S3
a 0 0 6 (46.2%)
S2/3 do not fuse 0 5 (50.0%) 13 (100%)
S3 to S4
b 0 0 13 (100%)
aThe lack of S1/S2 fusion is not always accompanied by an obvious
transformation of S2 to S3.
bThe lack of S2/S3 fusion is not always accompanied by an obvious
transformation of S3 to S4.
doi:10.1371/journal.pone.0004750.t002
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found in the neurectoderm and later in the CNS. In developing
mouse embryos, the Asxl2 gene trap expression is also detected
broadly at low levels. However, its expression is elevated in
selected tissues, including in the heart and in the axial skeleton.
The tissue-specific high level expression of the Asxl2 gene trap is
discernable in X-gal-stained whole-mount embryos (Fig. 2A) and is
better resolved when the embryos are cryo-sectioned (Fig. 2B–D).
In postnatal animals, expression of the Asxl2 gene trap is highly
tissue-specific (Fig. 2E–J). This differs from an earlier report on the
analysis of Asxl2 expression by Northern blot, which suggested
broad and relatively uniform expression of Asxl2 in six adult tissues
including the kidney, the lung, the heart, the salivary gland, the
skeletal muscle and the brain [34]. Highly similar Northern blot
pattern was reported for Asxl1 [34]. Although both gene trap and
Northern blot detected Asxl2 expression in the heart, the brain,
and the eye, the expression of the gene trap is much more tissue-
specific than what could be expected from the Northern blot.
Notably, the gene trap is not expressed in the kidney, the lung, the
skeletal muscle, or the postnatal brain.
One possible explanation for the discrepancy between our result
and the previous reported Northern blot is that insertion of the
gene trap disrupted regulatory element(s) within the first intron of
Asxl2. Sequence comparison between mouse, human and rat Asxl2
did not find conserved sequence modules at the site of gene trap
integration (Fig. 1B). However, we cannot exclude the formal
possibility that certain mouse-specific regulatory element(s) is
disrupted by the gene trap or that the gene trap insertion disrupted
critical spacing between regulatory elements. Alternatively, the
Northern blot probe used for Asxl2 may have cross-hybridized
with Asxl1 and/or Asxl3 transcripts. The 1.1-kb probe was made
from the EST clone AW496276, for which a partial sequence
(588 bp) is available from the IMAGE consortium. We blasted the
mouse genome with this partial sequence and found a 344-bp
region and a 379-bp region that exhibit sequence homology (69%
and above) with Asxl1 and Asxl2 transcripts, respectively. The
entire 1.1-kb probe may contain additional homologous sequenc-
es. Finally, Asxl2 gene has been suggested to have multiple
transcript isoforms. If any of the isoforms is transcribed from an
alternative promoter downstream of the gene trap cassette
insertion site, it would not be detected in the X-gal stainings.
Further analyses, including Northern blots and in situ hybridiza-
tions using highly Asxl2-specific probes and immunohistochemistry
studies of the Asxl2 protein, are needed to determine the
expression pattern of endogenous Asxl2 and to fully understand
the discrepancy between our result and previous report.
Interesting heart phenotypes and axial skeleton phenotypes
were observed in Asxl2 mutant animals, suggesting that the
expression of the gene trap in the heart and in the axial skeleton is
probably reflective of endogenous expression and function in these
tissues. Because of the strong expression of the Asxl2 gene trap in
the heart and in the axial skeleton, the current report
characterized the heart and skeleton phenotypes in further details
and focused on the heart when examining the effects of the gene
trap on endogenous Asxl2 transcription (Fig. 1F) and on histone
modifications (Fig. 5F, G).
The Asxl2 gene trap is expressed in the retina (Fig 2H);
Northern blot and EST profile also suggested that Asxl2 is
Figure 5. Cardiac phenotypes of Asxl2
2/2 animals. (A, B) H&E stainings of heart sections. The myocardial fibers, composed of cardiomyocytes,
are well organized in the wild-type heart (A). In contrast, the heart of a moribund 5-month-old Asxl2
2/2 mouse shows cardiomyocyte disarray (B). (C,
D) Examination of fibrosis in heart sections by Mason’s trichrome (MTC) staining. Blue staining marks regions of fibrosis. The mutant (D) but not the
wild-type (C) heart displays extensive interstitial fibrosis. (E) The heart/body weight ratios of mutant and control animals at 1 month, 2 months and 3
months after birth. The table below the chart shows the average ratio + standard deviation for each genotype and the p value for the time point.
Error bars in the chart represent standard deviations. (F, G) Western blot analysis of the levels of H3K27me3 and H3K4me3 in wild-type and mutant
hearts. As a control for equal loading, the blots were stripped and re-probed with an antibody against pan histone H3. The mutant heart has
decreased level of H3K27me3 (F). There is no obvious change in the level of H3K4me3 (G).
doi:10.1371/journal.pone.0004750.g005
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Asxl2 mutant mice have smaller, degenerating eyes compared to
wild-type animals (data not shown). A role for Asxl2 in the eye has
been previously speculated because a balanced reciprocal
translocation between human ASXL2 and the Gt4-2 locus was
discovered in a patient with bilateral colobomas in the retina and
iris [41]. Eye phenotypes in mice are severely influenced by
genetic background. Due to the mixed genetic background of
animals examined in the current report, the eye phenotypes of
Asxl2 mutant mice were not characterized.
Functional conservation of Asxl2
Analyses of Asxl2
2/2 mice show that Asxl2 has an important
role in animal survival and growth. The loss of Asxl2 activity results
in partial embryonic lethality, shortened life span of adult animals,
and a reduction in size and body weight. Similar phenotypes have
been previously described for mice mutant for the PcG gene M33
or the ETP gene Bmi-1 [42–43]. Both M33 and Bmi-1 are
associated with the PcG complex PRC1 [44]. Detailed analyses of
the genetic and biochemical interactions between Asxl2, M33 and
Bmi-1 are needed to shed light on whether and where Asxl2
regulates the function of the PRC1 complex.
Asxl2
2/2 mice exhibit a number of axial skeletal abnormalities
(Fig. 4H), indicating that Asxl2 has a role in the patterning of the
axial skeleton, where PcG, trxG and other known ETP genes
function. The trademark characteristic for ETP genes is their dual
roles in promoting both PcG and trxG activities. Such dual roles
have been shown for Drosophila Asx. We observed both posterior
transformations (S3-.S4 and S2-.S3) and anterior transforma-
tions (T7-.T6 and T4-.T3) in Asxl2
2/2 skeletons, suggesting
that the loss of Asxl2 disrupts both PcG and trxG activities in the
axial skeleton (Fig. 4). A compromise in PcG-associated HMTase
activity was also observed in Asxl2
2/2 hearts, which exhibit
reduced global level of H3K27me3 (Fig. 5F). It has been
previously shown that knockdown of E(z), the HMTase subunit
of PRC2, abolishes H3K27me3 in Drosophila [45]. Similarly,
knocking down of EZH2, a human homolog of E(z), led to a global
decrease in H3K27me3 in cancer cells [46]. We notice that while
H3K27me3 is completely abolished in E(z) knockdown cells, it is
significantly reduced but not abolished in EZH2 knockdown cells
or in Asxl2
2/2 hearts. A likely explanation is functional
redundancy between multiple homologs in mammals. Ezh1, the
other mammalian homolog for E(z), may be partially redundant
with Ezh2. Similarly, Asxl1 and Asxl3 may be partially redundant
with Asxl2. Alternatively, Asxl2
2/2 hearts may have residual Asxl2
activity since the gene trap does not completely abolish wild-type
Asxl2 transcripts (Fig. 1F).
In contrast to H3K27me3, the level of H3K4me3 did not
exhibit obvious change in Asxl2
2/2 hearts (Fig. 5G). This
observation could suggest a tissue difference in Asxl2’s function:
it may regulate trxG activity in the axial skeleton but not in the
heart. However, there are several alternative explanations. It is
possible that Asxl2 regulates trxG activity at only a subset of trxG
target loci. In this case, the loss of Asxl2 may reduce H3K4me3 at
the promoters of these loci without significant impact on the level
of bulk H3K4me3. Testing this hypothesis will require the
identification of Asxl2 target loci and he examination of local
H3K4me3 levels by chromatin immunoprecipitation (ChIP).
Alternatively, Asxl2 may specifically regulate the ATP-dependent
chromatin remodeling activity but not the HMTase activity of
trxG complexes. It will be interesting to compare the chromatin
remodeling activity of trxG complexes purified from wild-type and
Asxl2
2/2 hearts in the future. A third possibility is that there may
be a division of labor among mammalian Asx-like proteins, so that
Asxl2 primarily regulates PcG activity while trxG activity is
primarily regulated by Asxl1 or Asxl3. This last scenario would
predict that Asxl2 is more essential for PcG activity than for trxG
activity. Consistent with this scenario, even though both posterior
transformations and anterior transformations were observed in
Asxl2
2/2 skeletons, posterior transformations have a higher
penetrance (100% for S3-.S4 transformation vs. 23% for T7-
.T6 transformation). The generation of Asxl1 and Asxl3 mutant
animals will allow us to address the potential division of labor
among Asx-like proteins.
Role of Asxl2 in the heart
A PcG gene, Rae28, has previously been shown to be required
for sustaining the expression of the cardiac selector gene Nkx2.5 in
developing mouse embryos [47]. The loss of Rae28 disrupts an
early and important step of cardiac morphogenesis, cardiac
looping, that takes place between E8.5 and E9.5. Asxl2
2/2
animals that survived embryogenesis do not display any obvious
abnormalities in the gross morphology of the heart (data not
shown). However, some Asxl2
2/2 embryos died in utero and could
have more severe phenotypes than the ones that were born. A
detailed phenotypic characterization of Asxl2
2/2 embryos is
needed to answer whether Asxl2 plays a role in heart
morphogenesis. The variability in survival and/or in the severity
of phenotypes between individual embryos could be due to
variation in residual Asxl2 activity or functional redundancy
among Asx-like proteins.
In postnatal animals, cardiac function is known to be
epigenetically regulated. For example, class I and class II histone
deacetylases (HDACs) promote and inhibit cardiac hypertrophy,
respectively [48–49]. However, whether the PcG/trxG system
plays a role in postnatal heart is unclear, partly because the
embryonic lethality of many PcG/trxG mutations precluded
functional study of postnatal development. The Asxl2
2/2 animals
provide a good opportunity to address this question. A molecular
signature of cardiac hypertrophy is the reactivation of multiple
genes that are active during fetal development but repressed in the
adult heart [50]. Given the role of PcG proteins in the
maintenance of silenced loci, PcG proteins could be involved in
the repression of these genes in normal hearts. Two important
research directions in the future will be the full characterization of
the heart phenotypes of Asxl2
2/2 animals and the study of the
underlying mechanisms, especially the role of the PcG/trxG
system.
Materials and Methods
Generation of Asxl2 mutant mice
The AQ0356 gene trap ES cell line was purchased from the
Sanger Institute. The gene trap event in AQ0356 ES cell line was
confirmed with RT-PCR and with sequencing. For RT-PCR, total
RNA was extracted with Trizol (Invitrogen). 1 mg of RNA was
reverse transcribed with the R3 primer and SuperScript II reverse
transcriptase (Invitrogen). Reverse transcription using the R2
primer was performed in a separate tube as a control. PCR
reactions were performed using 1/7 of the cDNA product and
AmpliTag Gold (ABI). The anneal temperature was 58uC and 30
cycles of reactions were performed. Sequences for RT-PCR
primers are:
R1: 59-GCCTCCCAGTCAGTCAGAAC-39;
R2: 59-GTCCTTCTCTCTGGATAACC-39;
R3: 59-GTAATGGGATAGGTCACGT-39.
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confirm that the beta-geo reporter is joined to exon 1 after splicing.
AQ0356 ES cells were then expanded and injected into blastocysts.
Microinjection was performed by the Stanford Transgenic Facility.
Chimera mice were mated and the progeny were screened by
genotyping PCR for germ-line transmission. Three independent
lines, derived from three chimeras, were bred. The three lines were
indistinguishable in gene trap expression pattern and in phenotypes.
All the animals analyzed were in C57BL/6J-129S2 mixed genetic
background. The animal protocols were approved by the Animal
Care Committee (ACC) at the University of Illinois at Chicago.
Mapping gene trap integration site
A set of 30 forwardprimers that scan the 15-kb intron 1 of Asxl2at
0.5-kb interval were designed. PCR reactions were performed using
individual forward primer and the P3 reverse primer. An extension
timeof1 min.wasusedinthePCRreactions.Primers#10and#11
generated PCR products. The two products differ in length by
,0.5 kb, correlating with the ,0.5 kb distance between the two
primers. The PCR products were then sequenced to determine
where genomic sequence is joined to gene trap cassette sequence.
Genotyping PCR
Genomic DNA was prepared from clipped mouse tails following
standard protocols. PCR reactions were performed with the PCR
Master Mix (Qiagen). Sequences for genotyping PCR primers are:
P1: 59-CCAACCCAACAGTCAGTATG-39,
P2: 59-CAAATCTGCCTCATCCTCTC-39,
P3: 59-CTCTCCCATCCACTACTCAG-39
Real-time RT-PCR
Total heart RNA was extracted with Trizol (Invitrogen) from two
sets of wild-type, heterozygous and mutant mice. The RNA was
treated with DNaseI (Fermentas) andpurifiedwith RNeasycolumns
(Qiagen). Real-time RT-PCRs were performed on a DNA Engine
Opticon 2 system (Bio-Rad) using the SuperScript
TM III Platinum
SYBR Green One-Step qRT-PCR kit (Invitrogen). Three primer
pairs were tested. A pair of primers that straddle exons 9 and 10 of
Asxl2 exhibit the best melting curve and were used to generate the
data. 300 ng total RNA was used as template in each reaction.
Reactionconditions:50uCfor15 min,95uCfor5 min,and40cycles
of 95uC for 15 s, 60uC for 30 s, and 70uC for 1 min. The level of
Asxl2 transcripts was normalized against that of b-actin transcripts in
the same sample. Triplicate reactions were performed for each
primer pair (Asxl2 or b-actin) and each set of RNA samples.
Sequences of Asxl2 primers are:
Forward: 59-CTCCTGAAATGCAGGTGAGA-39
(within exon 9)
Reverse: 59-TTGCTTTGGGATCACTTGAG-39
(within exon 10)
Sequences of b-actin primers are:
Forward: 59-TCACCCACACTGGCCCATCTACGA-
39
Reverse: 59-TGGTGAAGCTGTAGCCACGCT-39
X-gal staining of embryos and postnatal tissues
Postnatal tissues and embryos were fixed at 4uCi n4 %
paraformaldehyde (PFA) for 1–2 hours. After fixation, postnatal
tissues were cross-sectioned or cut longitudinally into halves and
washed with Tissue Rinse A (2 mM MgCl2, 5 mM EGTA in PBS)
followed by Tissue Rinse B (2 mM MgCl2, 0.01% w/v sodium
deoxycholate, 0.02% w/v NP-40 in PBS) for 30 minutes each at
room temperature. Embryos were rinsed three times in Tissue
Rinse B for 10 minutes each. All specimens were transferred to
Staining Solution (5 mM potassium ferrocyanide, 5 mM potassi-
um ferrocyanide, 1 mg/ml X-gal in Tissue Rinse B) and stained at
37uC for 5 hours per day and stored at 4uC until color developed.
Tissues and embryos were then post-fixed in 4% PFA, equilibrated
in 30% sucrose and embedded in OCT.
Staining of axial skeletons
Adult mice carcasses were skinned and eviscerated. The
skeletons were fixed in 95% ethanol for 4 days and defatted in
acetone for 2 days. The skeletons were then incubated at 37uCi na
staining solution of 0.005% alizarin red (Sigma A5533), 0.015%
alcian blue (Sigma A3157), 90% ethanol, and 5% glacial acetic
acid for 3 days. The skeletons were rinsed in distilled water and
cleared in 1% KOH for 2 days. They were then switched into
0.8% KOH and 20% glycerol for 2 weeks, 0.5% KOH and 50%
glycerol for 1 week, 0.2% KOH and 80% glycerol for 1 week, and
finally stored in 100% glycerol.
Histology
Mice were euthanized by CO2 inhalation followed by cervical
dislocation. Hearts were immediately harvested, perfused with
10% formalin, and fixed in 10% formalin. Paraffin-embedding
and sectioning were performed at the Veterinary Diagnostic
Laboratory, University of Illinois at Urbana-Champaign. H&E
stainings were performed following standard protocols. For
Mason’s trichrome staining, 10 mm paraffin-embedded sections
were rehydrated and then incubated in pre-warmed Bouin’s
Solution in a 60uC water bath for 1 hour. After rinsing in running
tap water, the slides were incubated in Working Weigert’s
Hematoxylin solution (Sigma HT1079) for 5–15 minutes, de-
pending on the age of the solution. The slides were rinsed in
running tap water and then stained in Biebrich Scarlet-Acid
Fuschin solution (Sigma HT151) for 5 minutes. The slides were
rinsed in running tap water and placed in 25% Phosphomolybdic
acid solution/25% Phophotungstic acid solution (Sigma HT153,
HT152) for 10 minutes. The slides were placed in Aniline Blue
solution (Sigma HT154) for 5 minutes, rinsed in distilled H2O and
placed in 1% acetic acid for 1 minute. Finally, the slides were
dehydrated through a series of alcohols to xylene and mounted
using Cytoseal XYL Mounting Medium (Thermo Scientific DXD-
10140747).
Western blotting
Mice were euthanized by CO2 inhalation followed by cervical
dislocation. Hearts were immediately harvested and flash frozen in
a dry ice-ethanol bath. Frozen hearts were cut to small pieces on
dry ice and homogenized in hypotonic buffer (PBS containing
0.5% Triton X 100) supplemented with protease inhibitors
cocktail in a dounce homogenizer. Nuclei were collected by
centrifugation at 6,000 g for 15 minutes at 4uC and washed once
with hypotonic buffer. Histones were extracted over night at 4uC
from the nuclei pellet by 0.2N HCl. Insoluble fraction was cleared
by centrifugation at 6,000 g for 15 minutes at 4uC. The
supernatant (histone extract) was flash frozen in a dry ice-ethanol
bath after the protein concentration was measured by BCA assay.
Total histones was separated on 15% SDS-PAGE gels. After
transfer, membranes were blotted with mouse anti-H3K27me3 or
rabbit anti-H3K4me3. As a loading control, blotted membranes
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ECL reaction, and stripped membranes were blotted with rabbit
anti-pan histone H3. All antibodies were purchased from Active
Motifs.
Statistical analyses
Paired t-tests and Chi-square tests were performed using
GraphPad Software on-line statistical calculators (http://www.
graphpad.com/quickcalcs/ttest1.cfm and http://www.graphpad.
com/quickcalcs/chisquared1.cfm). Paired t-tests were used to
determine whether the weight difference between mutants and
controls were statistically significant (Figure 3A) and whether the
difference in the heart/body weight ratios of mutant and control
animals was statistically significance (Figure 5E). Two-tailed p
values were calculated and shown in the figures. Chi-square tests
were used to determine whether the actual numbers of
heterozygous and mutant animals born were statistically different
from those expected based on the number of wild-type animals.
Two-tailed p value was calculated for each genotype.
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